ArticleBlood advances2026
Decitabine-cedazuridine in patients with MDS and TP53 mutations.
Samuel Urrutia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papertrialcites it
ArticleBlood advances2026
Samuel Urrutia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.